MetaCap

Hemab Therapeutics Holdings Inc. (COAG)

NASDAQ: COAGHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

28.70+0.33 (+1.16%)

At close: Oct 7, 4:00 PM ET · Delayed 15 min

After hours: 28.70 0.00%

COAG stock chart

Technical analysis

Key statistics

All statistics
EPS (TTM)
-$4.33
52-week range
23.00 – 55.42
Day range
27.38 – 28.98
Volume / Avg
370.75K / 453.50K
Beta
—

52-week range

$23.00$55.42

COAG stock today

Shares of Hemab Therapeutics (COAG) finished higher on Oct 7 at $28.70, a gain of 1.16% or $0.33 per share, versus the S&P 500's 0.22% decline. At this level, COAG sits near the bottom of its 52-week range of $23.00 to $55.42: 48.2% below the high and 24.8% above the low. Hemab Therapeutics has posted a net loss over the last twelve months (EPS of -$4.33), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About Hemab Therapeutics

Company profile
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
IPO year
2026

Hemab Therapeutics peers

Health Care sector
COAG peer companies
CompanyPrice% ChgMarket capCompare
INBXInhibrx Biosciences Inc.93.36-0.05%$1.37Bvs COAG
REPLReplimune Group Inc.13.20-0.38%$1.24Bvs COAG
TSHATaysha Gene Therapies Inc.4.43+0.91%$1.44Bvs COAG
MAZEMaze Therapeutics Inc.26.25-0.68%$1.46Bvs COAG
IMCRImmunocore Holdings plc ADR29.41-0.47%$1.51Bvs COAG
IMTXImmatics N.V.7.45-0.67%$1.13Bvs COAG
VORVor Biopharma Inc.18.78+2.57%$1.11Bvs COAG
MGTXMeiraGTx Holdings plc10.82+2.08%$1.04Bvs COAG

Indexes, lists and sector

Hemab Therapeutics stock FAQ

What is Hemab Therapeutics's stock price today?

COAG last traded at $28.70 as of Oct 7, 4:00 PM EDT, up 1.16% on the day. Prices are delayed at least 15 minutes.

What is the COAG 52-week high?

The 52-week high for COAG is $55.42 and the 52-week low is $23.00. The stock is currently 48.2% below its high.

Compare COAG